NCT03437109View on ClinicalTrials.gov

Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus

CompletedOBSERVATIONAL

Enrollment

554

Participants

Timeline

Start Date

December 6, 2017

Primary Completion Date

February 1, 2019

Study Completion Date

February 1, 2019

Conditions

T2DM (Type 2 Diabetes Mellitus)Hypogonadism

Interventions

DIAGNOSTIC_TEST

Laboratory tests

Testosterone HSBG Hb1Ac LH

Trial Locations (2)

117036

ENC, Moscow

121359

Central Clinical Hospital, Moscow

Sponsors

Lead Sponsor

Besins Healthcare

All Listed Sponsors

lead

Besins Healthcare

INDUSTRY

NCT03437109 - Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter